ON YOUR MIRADRY TREATMENT*
The submission period for this rebate offer closed on April 15th, 2025, and we are unable to process submissions received after this date.
" " indicates required fields
*Valid on treatments performed January 1st – March 31st, 2025; must redeem by April 15, 2025.
International Hyperhidrosis Society, sweathelp.org • Clinical Evaluation of a Microwave Device for Treating Axillary Hyperhidrosis. Hong et al; Dermatologic Surgery 2012. • Long-term Efficacy and Quality of Life Assessment for Treatment of Axillary Hyperhidrosis With a Microwave Device. Mark Lupin, MD et al; Dermatol Surg 2014; 40: 805-807. • Retrospective Multistudy Analysis of Axillary Odor Reduction After Microwave Treatment, Sarah Yagerman, MD et al; American Society for Dermatologic Surgery, Inc.; 2018. • Taylor NAS, Machado-Moreira CA. Regional variations in transepidermal water loss, eccrine sweat gland density, sweat secretion rates and electrolyte composition in resting and exercising humans. Extrem Physiol Med. 2013;2:4 • Data on file. miraDry, Inc. • A Prospective Study of Axillary Hair Reduction in Patients Treated With Microwave Technology. Jeremy A. Brauer, MD et al; American Society for Dermatologic Surgery, Inc. 2016.
Models featured on the website are not real patients.
For additional safety information please click here. The miraDry system is FDA-cleared for the treatment of unwanted underarm sweat and odor, as well as the permanent removal of unwanted underarm hair. Outside the U.S., the miraDry system is intended for use by health care professionals for treatment of primary axillary hyperhidrosis (excessive sweating). Patient results and experience may vary. miraDry® and miraDry fresh™ are trademarks of miraDry, Inc. Products may be covered by one or more U.S. Patents. Please click here to see patents associated with individual miraDry, Inc. products.
